Targeting Cancer with CRISPR/Cas9-Based Therapy

Cancer is a devastating condition characterised by the uncontrolled division of cells with many forms remaining resistant to current treatment. A hallmark of cancer is the gradual accumulation of somatic mutations which drive tumorigenesis in cancerous cells, creating a mutation landscape distinctiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Balon, Katarzyna, Sheriff, Adam, Jacków, Joanna, Łaczmański, Łukasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745084/
https://www.ncbi.nlm.nih.gov/pubmed/35008996
http://dx.doi.org/10.3390/ijms23010573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745084/
https://www.ncbi.nlm.nih.gov/pubmed/35008996
http://dx.doi.org/10.3390/ijms23010573

Ejemplares similares